Sandoz inaugurates oncology manufacturing plant in Kalwe, India

Sandoz Technical Operations, a Novartis division, inaugurated a new manufacturing plant for oral cancer medicines at Kalwe in Mumbai, India. The facility spans 32,000 sq mt, currently employs 70 people with plans to recruit 200 more, and will produce Olaparib, Darolutamide and Lenvatinib for global export.

“The new facility will produce medicines focused in the areas of oncology, covering both cancer and blood disorders.”indiamedtoday.com

• 1 source
• indiamedtoday.comSandoz Technical Operations launches manufacturing plant in Maharashtra - IndiaMedTodayIMT News DeskJun 30, 2022

Summarized from public sources; check the original articles before acting on it.